Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Zaccone

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Diabetes|July 30, 1999
Interleukin-13 prevents autoimmune diabetes in NOD miceP Zaccone, J Phillips, I Conget, et al.
Immunology Letters|April 30, 1998
Deoxyspergualin neither counteracts lipopolysaccharide (LPS) or Staphylococcus aureus enterotoxin-B (SEB) induced lethality in mice nor does it modulate the release of tumor necrosis factor-alphaR Di Marco, P Zaccone, L Condorelli, et al.
Diabetes|December 2, 1999
Early prophylaxis with recombinant human interleukin-11 prevents spontaneous diabetes in NOD miceF Nicoletti, P Zaccone, I Conget, et al.
Journal of Chemotherapy (Florence, Italy)|October 1, 1993
The effect of cefepime on some immune parameters in vitro: lack of interference with mitogen-induced lymphoproliferation, immunoglobulin synthesis, IFN-gamma and IL-2 secretion and IL-2 receptor expressionR Di Marco, I Carrabba, V Cavallaro, et al.
European Journal of Pharmacology|March 17, 1999
Prevention by rolipram of concanavalin A-induced T-cell-dependent hepatitis in miceM Xiang, P Zaccone, R Di Marco, et al.
Journal of Chemotherapy (Florence, Italy)|May 18, 1999
Prophylaxis with the novel immunomodulator pidotimod reduces the frequency and severity of upper respiratory tract infections in children with Down's syndromeI La Mantia, C Grillo, T Mattina, et al.
Immunology|February 1, 1994
Reduction of spontaneous autoimmune diabetes in diabetes-prone BB rats with the novel immunosuppressant fusidic acid. Effect on T-cell proliferation and production of interferon-gammaF Nicoletti, R Di Marco, S Morrone, et al.
Clinical and Experimental Immunology|August 11, 1998
Blood levels of transforming growth factor-beta 1 (TGF-beta1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-beta1b)F Nicoletti, R Di Marco, F Patti, et al.
Scandinavian Journal of Immunology|November 1, 1994
The effects of thymopentin on the development of SLE-like syndrome in the MRL/lpr-lpr mouseF Nicoletti, P Zaccone, G Magro, et al.
Cytokine|June 14, 2000
Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)-beta1B transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta, IL-2, IL-4 and tumour necrosis factor-alphaF Nicoletti, R Di Marco, F Patti, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Diabetes|July 30, 1999
Interleukin-13 prevents autoimmune diabetes in NOD miceP Zaccone, J Phillips, I Conget, et al.
Immunology Letters|April 30, 1998
Deoxyspergualin neither counteracts lipopolysaccharide (LPS) or Staphylococcus aureus enterotoxin-B (SEB) induced lethality in mice nor does it modulate the release of tumor necrosis factor-alphaR Di Marco, P Zaccone, L Condorelli, et al.
Diabetes|December 2, 1999
Early prophylaxis with recombinant human interleukin-11 prevents spontaneous diabetes in NOD miceF Nicoletti, P Zaccone, I Conget, et al.
Journal of Chemotherapy (Florence, Italy)|October 1, 1993
The effect of cefepime on some immune parameters in vitro: lack of interference with mitogen-induced lymphoproliferation, immunoglobulin synthesis, IFN-gamma and IL-2 secretion and IL-2 receptor expressionR Di Marco, I Carrabba, V Cavallaro, et al.
European Journal of Pharmacology|March 17, 1999
Prevention by rolipram of concanavalin A-induced T-cell-dependent hepatitis in miceM Xiang, P Zaccone, R Di Marco, et al.
Journal of Chemotherapy (Florence, Italy)|May 18, 1999
Prophylaxis with the novel immunomodulator pidotimod reduces the frequency and severity of upper respiratory tract infections in children with Down's syndromeI La Mantia, C Grillo, T Mattina, et al.
Immunology|February 1, 1994
Reduction of spontaneous autoimmune diabetes in diabetes-prone BB rats with the novel immunosuppressant fusidic acid. Effect on T-cell proliferation and production of interferon-gammaF Nicoletti, R Di Marco, S Morrone, et al.
Clinical and Experimental Immunology|August 11, 1998
Blood levels of transforming growth factor-beta 1 (TGF-beta1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-beta1b)F Nicoletti, R Di Marco, F Patti, et al.
Scandinavian Journal of Immunology|November 1, 1994
The effects of thymopentin on the development of SLE-like syndrome in the MRL/lpr-lpr mouseF Nicoletti, P Zaccone, G Magro, et al.
Cytokine|June 14, 2000
Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)-beta1B transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta, IL-2, IL-4 and tumour necrosis factor-alphaF Nicoletti, R Di Marco, F Patti, et al.
Pageof 3